BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  BioCapital

  Vantage Report 2018: Research Dragged, but Biotech IPOs and Startups Soared

  Evaluate recently published the Vantage Pharma, Biotech and Medtech 2018 in review report. The annual report offers insights into the previous year’s activities in biopharma and the medical device industry.

  February 28, 2019

   · 

  5 min read

   · 

  Mark Terry
• 

  Deals

  UPDATE: Two of BMS’ Biggest Shareholders Object to Celgene Acquisition

  Shares of Bristol-Myers Squibb took a hit Wednesday after two large stakeholders in the company objected to the pending acquisition of Celgene. Wellington and Starboard Value have both publicly voiced opposition to the deal.

  February 28, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Novavax RSV Vaccine Fails to Hit Primary Endpoint in Phase III Trial

  Shares of Maryland-based Novavax are down 66 percent in morning trading after the company announced its respiratory syncytial virus (RSV) vaccine called ResVax failed to hit its primary endpoint in a Phase III trial.

  February 28, 2019

   · 

  2 min read

   · 

  Alex Keown
• Job Trends

  Liquid biopsy as effective as tissue biopsy for non-small cell lung cancer according to MD Anderson study

  Test more accurately identifies four mutations for which FDA-approved drugs exist and offers faster turn-around time between initial testing and commencement of therapy

  February 28, 2019

   · 

  3 min read
• Business

  Althea Group Holdings Limited (ASX:AGH): Half Year Financial Report & Appendix 4D For the period ended 31 December 2018

  Althea Group Holdings Limited is pleased to provide its Half Year Financial Report and Appendix 4D.

  February 28, 2019

   · 

  1 min read
• Business

  MDxHealth (R): MDxHealth Reports Financial Year 2018 Results and Provides Outlook for 2019

  MDxHealth SA, announced its business update and financial results for the year ended December 31, 2018 and provided its strategic outlook for 2019.

  February 28, 2019

   · 

  7 min read
• Drug Development

  Amryt Pharma plc (“Amryt” or the “Company”) Update on AP101 EASE Phase III trial

  IDMC recommends study can enrol children and infants aged from 21 days to 4 years

  February 28, 2019

   · 

  3 min read
• Medigene AG: Medigene presents poster on in vitro evaluation of TCR efficacy and toxicity at AACR

  Medigene AG announced that researchers of the Company will present a poster at the 2019 American Association for Cancer Research Annual Meeting.

  February 28, 2019

   · 

  2 min read
• Global Food Industries reaps two topmost awards for Innovation excellence at UAE Innovation Awards 2019

  February 28, 2019

   · 

  4 min read
• Medtronic Announces Approval and Launch of Japan’s First DBM Bone Grafting Product for Spine and Orthopedic Procedures

  Grafton(TM) DBM Product Will Provide More Options for Spine and Orthopedic Surgeons in Japan

  February 28, 2019

   · 

  2 min read